Another of Elon Musk’s greatest experimental projects is Neuralinking, a technology that would enable the formation of brain-computer interfaces to connect the human brain to any technological device.
According to a report, the project’s primary objectives are targeted at helping with various medical issues such as blindness, hearing loss, and paralysis, but in some cases, the chips could also help us blur the distance that exists between our brain and any other technological device, such as a mobile phone.
Neuralinking chips have been tested on living beings such as monkeys in recent months, allowing them to play Pong with their minds. They now want to push even further. The company is currently looking for human candidates to test this new technology, and Neuralink is looking for a director of clinical trials to help with that.
The advertisement reads
“you’ll work closely with some of the most innovative doctors and top engineers, as well as work with Neuralink’s first clinical trial participants.” According to the job description, “you will lead and help build the team responsible for enabling Neuralink’s clinical research activities and developing the regulatory interactions that come with a fast-paced and ever-changing environment.”
He continues, “I will lead and assist in the development of the team responsible for enabling Neuralink’s clinical research activities and developing the regulatory interactions that come with a fast-paced and constantly evolving environment.”
Moreover, Musk stated that “with Neuralink, we have the opportunity to restore functionality to the entire body of someone who has a spinal cord injury.” “Neuralink is working well in monkeys, and we’re doing a lot of testing to confirm that it’s very secure and reliable, as well as that the device can be safely removed.”
“The first Neuralink product will allow someone with paralysis to use a smartphone with their mind faster than someone using their thumbs,” Last year a tweet from the Tesla CEO rolled out reinforcing the company’s sole objectives. Future versions will be able to shunt signals from Neuralinks in the brain to Neuralinks in body motor/sensory neuron clusters, allowing paraplegics, for example, to walk again.